asthma,  beth Seidenberg,  Kleiner Perkins Caufield & Byers,  kpcb,  pain,  TC

M.D. Turned VC Beth Seidenberg To Talk Biotech Startups At Disrupt SF

Beth Seidenberg is a licensed physician immunologist who helped bring drugs like the asthma drug Singulair and the pain medication Vioxx to market before turning to venture capitalism. As a partner at Kleiner Perkins Caufield & Byers (KPCB), she’s helped develop companies that led to some pretty sizable exits, and we’re thrilled to announce that Seidenberg will be talking with… Read More

Comments Off on M.D. Turned VC Beth Seidenberg To Talk Biotech Startups At Disrupt SF